Suppr超能文献

基于网络药理学和分子对接技术探索平心定志汤的治疗机制

Exploring the Therapeutic Mechanism of Pingxin Dingzhi Decoction Through Network Pharmacology and Molecular Docking.

作者信息

Ju Xiaojie, Qi Chunhua, Bai Yulong, Li Pengfei, He Kuanjun

机构信息

School of Medical Technology, Baicheng Medical College, Baicheng, China.

College of Life Sciences and Food Engineering, Inner Mongolia Minzu University, Tongliao, China.

出版信息

Alpha Psychiatry. 2024 Sep 1;25(5):584-591. doi: 10.5152/alphapsychiatry.2024.241642. eCollection 2024 Sep.

Abstract

OBJECTIVE

Studies have demonstrated that the combination of antipsychotics and Pingxin Dingzhi Decoction (PXDZD) can effectively enhance treatment efficacy for schizophrenia (SCZ), while simultaneously reducing the adverse reactions associated with antipsychotic treatment. However, the exact mechanism by which PXDZD exerts its therapeutic effects is still unknown. The aim of this study is to investigate the action mechanism of PXDZD using network pharmacology and molecular docking techniques.

METHODS

The primary components and their protein targets of PXDZD were extracted from TCMSP, SYMMAP, and HERB databases. The targets related to SCZ were acquired from OMIM and DisGeNET databases. The overlapping targets between composite targets and disease targets were used to construct a protein-protein interaction (PPI) network in the STRING database. The identified targets underwent GO and KEGG enrichment analysis, followed by molecular docking studies of the core target proteins and active compounds.

RESULT

The screening process yielded 285 PXDZD component targets and 1982 disease targets, ultimately leading to the identification of 120 shared targets. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis revealed that PXDZD treatment for SCZ engages a diverse range of biological mechanisms, including inflammatory responses and apoptotic processes, while also modulating various signaling pathways such as the PI3K-Akt, mitogen-activated protein kinase (MAPK), and tumor necrosis factor (TNF) signaling pathways. The molecular docking results revealed a strong affinity of Estrogen Receptor 1 (ER1) toward both β-sitosterol and stigmasterol, while kaempferol, β-sitosterol, and stigmasterol demonstrated significant binding potential against TNF-α.

CONCLUSION

Pingxin Dingzhi Decoction can play a role in treating SCZ through its multi-component, multi-target, and multi-pathway approach.

摘要

目的

研究表明,抗精神病药物与平心定志汤(PXDZD)联合使用可有效提高精神分裂症(SCZ)的治疗效果,同时减少抗精神病药物治疗相关的不良反应。然而,PXDZD发挥治疗作用的确切机制尚不清楚。本研究旨在利用网络药理学和分子对接技术探讨PXDZD的作用机制。

方法

从中药系统药理学数据库(TCMSP)、SymMap数据库和中药综合数据库(HERB)中提取PXDZD的主要成分及其蛋白质靶点。从在线孟德尔人类遗传数据库(OMIM)和疾病基因数据库(DisGeNET)中获取与SCZ相关的靶点。在STRING数据库中,利用复合靶点与疾病靶点之间的重叠靶点构建蛋白质-蛋白质相互作用(PPI)网络。对鉴定出的靶点进行基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析,随后对核心靶点蛋白和活性化合物进行分子对接研究。

结果

筛选过程产生了285个PXDZD成分靶点和1982个疾病靶点,最终确定了120个共同靶点。基因本体(GO)和京都基因与基因组百科全书(KEGG)分析表明,PXDZD治疗SCZ涉及多种生物学机制,包括炎症反应和凋亡过程,同时还调节多种信号通路,如磷脂酰肌醇-3激酶-蛋白激酶B(PI3K-Akt)、丝裂原活化蛋白激酶(MAPK)和肿瘤坏死因子(TNF)信号通路。分子对接结果显示,雌激素受体1(ER1)对β-谷甾醇和豆甾醇均具有较强的亲和力,而山奈酚、β-谷甾醇和豆甾醇对TNF-α具有显著的结合潜力。

结论

平心定志汤可通过其多成分、多靶点、多途径的方式发挥治疗SCZ的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222c/11562628/d9e844c4c763/ap-25-5-584_f001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验